English

BioStock: Alligator’s mitazalimab data published in The Lancet Oncology

Report this content

Alligator Bioscience’s phase II data with cancer immunotherapy mitazalimab have been published in The Lancet Oncology – one of the most prestigious and internationally trusted scientific journals in the world. BioStock spoke with Alligator’s CEO Søren Bregenholt to get his reaction.

Read the article at biostock.se:

Alligator’s mitazalimab data published in The Lancet Oncology - BioStock

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Subscribe

Documents & Links

Quick facts

BioStock: Alligator’s mitazalimab data published in The Lancet Oncology
Tweet this